Evidence map›Paper›PMID 26854576›Full record

ArticleInternational immunopharmacology2016

The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells.

Andrea Gray, Ileana Marrero-Berrios, Jonathan Weinberg, Devasena Manchikalapati, Joseph SchianodiCola, Rene S Schloss, Joel Yarmush

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in International immunopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03382925 (Do Cervical Interlaminar Epidural Steroid Injections With Low-dose Lidocaine Cause Transient Objective Upper Extremity Weakness? A Prospective Randomized), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03382925 phase4terminatednot on this mapstarted 2017, after this paper: background citation

Do Cervical Interlaminar Epidural Steroid Injections With Low-dose Lidocaine Cause Transient Objective Upper Extremity Weakness? A Prospective Randomized

TypeinterventionalSponsorUniversity of UtahRan2017 to 2020Enrolled16ConditionsCervical RadiculopathyArmscervical interlaminar with lidocaine, cervical interlaminar with normal saline, Lidocaine, Triamcinolone Acetonide, Normal saline
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Osteoarthritis and cartilage open · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula with Adipose-Derived Mesenchymal Stem Cells.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andrea GrayDepartment of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Ileana Marrero-BerriosDepartment of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Jonathan WeinbergDepartment of Anesthesiology, New York Methodist Hospital, Brooklyn, NY, USA.
Devasena ManchikalapatiDepartment of Anesthesiology, New York Methodist Hospital, Brooklyn, NY, USA.
Joseph SchianodiColaDepartment of Anesthesiology, New York Methodist Hospital, Brooklyn, NY, USA.
Rene S SchlossDepartment of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ, USA. Electronic address: schloss@soemail.rutgers.edu.
Joel YarmushDepartment of Anesthesiology, New York Methodist Hospital, Brooklyn, NY, USA.
NewYork–Presbyterian Brooklyn Methodist Hospital · USRutgers, The State University of New Jersey · US

Funding

UMDNJ TRAINING GRANT IN BIOTECHNOLOGYT32GM008339 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI YARMUSH, MARTIN L · 1989 to 2019
$6.1M
NIGMS NIH HHS T32 GM008339NIGMS NIH HHS T32 GM8339
6 · The paper itself

Abstract

Administering local anesthetics (LAs) peri- and post-operatively aims to prevent or mitigate pain in surgical procedures and after tissue injury in cases of osteoarthritis (OA) and other degenerative diseases. Innovative tissue protective and reparative therapeutic interventions such as mesenchymal stromal cells (MSCs) are likely to be exposed to co-administered drugs such as LAs. Therefore, it is important to determine how this exposure affects the therapeutic functions of MSCs and other cells in their target microenvironment. In these studies, we measured the effect of LAs, lidocaine and bupivacaine, on macrophage viability and pro-inflammatory secretion. We also examined their effect on modulation of the macrophage pro-inflammatory phenotype in an in vitro co-culture system with MSCs, by quantifying macrophage tumor necrosis factor (TNF)-α secretion and MSC prostaglandin E2 (PGE2) production. Our studies indicate that both LAs directly attenuated macrophage TNF-α secretion, without significantly affecting viability, in a concentration- and potency-dependent manner. LA-mediated attenuation of macrophage TNF-α was sustained in co-culture with MSCs, but MSCs did not further enhance this anti-inflammatory effect. Concentration- and potency-dependent reductions in macrophage TNF-α were concurrent with decreased PGE2 levels in the co-cultures further indicating MSC-independent macrophage attenuation. MSC functional recovery from LA exposure was assessed by pre-treating MSCs with LAs prior to co-culture with macrophages. Both MSC attenuation of TNF-α and PGE2 secretion were impaired by pre-exposure to the more potent bupivacaine and high dose of lidocaine in a concentration-dependent manner. Therefore, LAs can affect anti-inflammatory function by both directly attenuating macrophage inflammation and MSC secretion and possibly by altering the local microenvironment which can secondarily reduce MSC function. Furthermore, the LA effect on MSC function may persist even after LA removal.

Indexed as

Anesthetics, LocalAnti-Inflammatory AgentsBupivacaineCell DifferentiationCells, CulturedCellular MicroenvironmentCoculture TechniquesDinoprostoneHumansImmunomodulationLidocaineMacrophagesMesenchymal Stem CellsTumor Necrosis Factor-alphaAnesthetics, LocalAnti-Inflammatory AgentsBupivacaineDinoprostoneLidocaineTumor Necrosis Factor-alphaInflammationLocal anestheticsMacrophagesMesenchymal stromal cells

Identifiers

PMID26854576
PMCPMC4779686
OpenAlexW2272260395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.